한글목차

세계 중요 장기 지원 시스템 및 의료용 바이오닉스 시장의 미래는 병원 및 외래수술센터(ASC) 시장에 기회가 있으며, 유망한 것으로 전망되고 있습니다. 세계 중요 장기 지원 시스템 및 의료용 바이오닉스 시장은 2025-2031년 연평균 10.1%의 성장률을 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 장기부전 및 만성질환의 유병률 증가와 장기 부족으로 인한 생명유지장비에 대한 수요가 증가하고 있다는 점입니다.

• Lucintel의 예측에 따르면 제품 유형별로는 중요 장기 지원 시스템이 가장 높은 성장세를 보일 것으로 예측됩니다.
• 최종 용도별로는 병원이 높은 성장세를 보일 것으로 예측됩니다.
• 지역별로는 북미가 가장 높은 성장이 예상됩니다.

중요 장기 지원 시스템 및 의료용 바이오닉스 시장의 전략적 성장 기회

중요 장기 지원 시스템 및 의료용 바이오닉스 시장은 기술 발전과 환자 니즈의 변화로 인해 전략적 성장 기회를 맞이하고 있습니다. 기업과 이해관계자들은 이러한 기회를 활용하여 제품을 강화하고 시장에서의 입지를 확대할 수 있습니다. 이 역동적인 산업에서 성장할 수 있는 5가지 주요 분야는 다음과 같습니다.

• 연구개발에 대한 투자: 연구개발에 대한 투자 확대는 장기 재생 및 바이오닉스 기술의 비약적인 발전으로 이어져 진화하는 의료 수요에 대응할 수 있는 혁신적인 제품을 생산할 수 있습니다.
• 신흥 시장 진출: 신흥 국가를 타겟으로 저렴한 가격의 바이오닉스 솔루션과 장기 지원 시스템을 제공하여 의료 격차를 해소하고 필수 기술에 대한 접근성을 향상시킬 수 있습니다.
• 기술 기업과의 제휴: 기술 기업과의 제휴를 통해 AI, IoT, 데이터 분석을 통합하여 의료기기의 성능과 사용 편의성을 향상시키고 제품의 능력을 향상시킬 수 있습니다.
• 맞춤형 의료 접근: 개별 환자의 프로파일에 따라 맞춤형 장기 지원 시스템을 개발함으로써 치료 효과를 크게 향상시키고, 특정 요구에 대응하며, 치료 결과를 향상시킬 수 있습니다.
• 재활 기술에 집중: 의족 사용자를 위한 첨단 재활 솔루션에 투자함으로써 새로운 시장을 창출하고 환자의 완전한 기능 회복과 삶의 질 향상을 실현할 수 있습니다.

이러한 전략적 성장 기회를 활용함으로써 중요 장기 지원 시스템 및 의료용 바이오닉스 분야의 이해관계자들은 시장 범위를 확대하는 동시에 혁신을 촉진하고 환자 치료를 개선할 수 있습니다.

중요 장기 지원 시스템 및 의료용 바이오닉스 시장 시장 성장 촉진요인 및 과제

중요 장기 지원 시스템 및 의료용 바이오닉스 시장은 성장 궤도를 형성하는 다양한 촉진요인과 과제에 영향을 받고 있습니다. 이러한 요인을 이해하는 것은 진화하는 시장 상황을 효과적으로 헤쳐 나가고자 하는 이해관계자들에게 필수적인 요소입니다. 여기서는 성장을 가속하는 5가지 주요 촉진요인과 이 분야의 발전을 저해할 수 있는 3가지 과제를 소개합니다.

주요 장기 지원 시스템 및 의료용 바이오닉스 시장을 촉진하는 요인은 다음과 같습니다.

• 만성질환 증가: 당뇨병, 심장병, 신부전 등 만성질환의 유병률이 증가함에 따라 환자의 예후를 개선하기 위한 장기 지원 시스템 및 바이오닉스 솔루션에 대한 수요가 증가하고 있습니다.
• 기술 발전: 재료, AI, 로봇 공학의 끊임없는 혁신은 의료용 바이오닉스 장비의 기능성과 효율성을 향상시켜 의료진과 환자 모두에게 매력적으로 다가갈 수 있도록 합니다.
• 인구 고령화: 고령 인구 증가는 장기 지지대 및 인공 보조기구를 포함한 의료 수요 증가에 기여하고, 그 결과 이러한 필수 기술 시장이 확대될 것입니다.
• 좋은 규제 환경: 각국 정부의 지원적인 규제와 장려 조치는 연구개발을 촉진하고 혁신적인 의료기기의 승인 절차를 가속화하고 있습니다.
• 의료비 지출 증가: 의료 서비스 및 기술에 대한 지출 증가는 첨단 장기 보조 시스템 및 바이오닉스 시스템에 대한 투자를 확대하여 시장 성장을 가속할 것입니다.

주요 장기 지원 시스템 및 의료용 바이오닉스 시장이 해결해야 할 과제는 다음과 같습니다.

• 높은 개발 비용: 연구개발과 규제 준수를 위해 많은 자금이 필요하므로 이 분야의 기술 혁신을 목표로 하는 신규 진출기업이나 중소기업에게는 장벽이 될 수 있습니다.
• 규제 장애물: 복잡한 규제 경로와 엄격한 승인 절차로 인해 신기술 도입이 지연되고 환자의 생명을 구할 수 있는 장비에 대한 적시 접근을 방해합니다.
• 낮은 인지도와 접근성: 사용 가능한 솔루션에 대한 인식 부족은 사회경제적 요인과 결합하여, 특히 서비스가 충분하지 않은 지역사회에서 중요한 장기 지원 시스템 및 의료용 바이오닉스에 대한 접근성을 제한할 수 있습니다.

중요 장기 지원 시스템 및 의료용 바이오닉스 시장은 강력한 촉진요인에 의해 지원되고 있지만, 지속가능한 성장과 환자 치료 개선을 보장하기 위해 해결해야 할 과제에 직면해 있습니다.

목차

제1장 개요

제2장 세계의 중요 장기 지원 시스템·의료용 바이오닉스 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 중요 장기 지원 시스템·의료용 바이오닉스 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 중요 장기 지원 시스템·의료용 바이오닉스 시장 : 제품 유형별
  • 중요 장기 지원 시스템
  • 의료용 바이오닉스
  • 정형외과용 바이오닉스
  • 심장용 바이오닉스
  • 신경용 바이오닉스
• 세계의 중요 장기 지원 시스템·의료용 바이오닉스 시장 : 최종 용도별
  • 병원
  • 외래 수술 센터
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 중요 장기 지원 시스템·의료용 바이오닉스 시장 : 지역별
• 북미의 중요 장기 지원 시스템·의료용 바이오닉스 시장
• 유럽의 중요 장기 지원 시스템·의료용 바이오닉스 시장
• 아시아태평양의 중요 장기 지원 시스템·의료용 바이오닉스 시장
• 기타 지역의 중요 장기 지원 시스템·의료용 바이오닉스 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 중요 장기 지원 시스템·의료용 바이오닉스 시장의 성장 기회 : 제품 유형별
  • 세계의 중요 장기 지원 시스템·의료용 바이오닉스 시장의 성장 기회 : 최종 용도별
  • 세계의 중요 장기 지원 시스템·의료용 바이오닉스 시장의 성장 기회 : 지역별
• 세계의 중요 장기 지원 시스템·의료용 바이오닉스 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 중요 장기 지원 시스템·의료용 바이오닉스 시장의 생산능력 확대
  • 세계의 중요 장기 지원 시스템·의료용 바이오닉스 시장에서의 기업인수합병(M&A), 합병사업
  • 인증과 라이선싱

제7장 주요 기업의 개요

• Abbott Laboratories
• Abiomed
• Baxter International
• Asahi Kasei
• Cochlear
• Boston Scientific
• Jarvik Heart
• Edwards Lifesciences
• Ossur Americas
• Medtronic

영문목차

The future of the global vital organ support systems and the medical bionic market looks promising, with opportunities in the hospital and ambulatory surgical center markets. The global vital organ support systems and medical bionic market is expected to grow with a CAGR of 10.1% from 2025 to 2031. The major drivers for this market are the growing prevalence of organ failure and chronic diseases and the rising demand for life-saving organ support systems amid organ shortage.

• Lucintel forecasts that, within the product type category, the vital organs support system is expected to witness the highest growth.
• Within the end use category, the hospital is expected to witness higher growth.
• In terms of regions, North America is expected to witness the highest growth.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Vital Organ Support Systems and Medical Bionic Market

The vital organ support systems and medical bionic market are rapidly evolving, driven by technological advancements and increasing patient needs. These trends reflect the integration of innovative technologies that enhance the quality of care and patient outcomes. Here are five key emerging trends shaping the future of this market.

• Advanced Bioprinting: Bioprinting technologies are evolving to create complex tissues and organs, allowing for personalized medicine approaches and reducing reliance on donor organs.
• Artificial Intelligence Integration: AI is used to analyze patient data in real time, improving decision-making in organ support systems and enhancing the functionality of bionic devices.
• Wearable Health Monitors: Smart wearables equipped with sensors are becoming prevalent, offering continuous monitoring of vital signs and supporting early intervention for patients with organ failures.
• Regenerative Medicine Advances: Research in stem cell therapies and tissue engineering paves the way for potential treatments that restore organ function, reducing the need for transplants.
• Bionic Limbs with Sensory Feedback: New bionic limbs incorporate sensory feedback mechanisms, providing users with a more natural experience and greater control over movement and functionality.

These emerging trends signify a transformative phase in the vital organ support and medical bionic sectors, promising enhanced patient care and improved health outcomes shortly.

Recent Developments in the Vital Organ Support Systems and Medical Bionic Market

Recent innovations in vital organ support systems and the medical bionic market are revolutionizing patient care. These developments reflect a commitment to enhancing organ function and improving the quality of life for individuals with chronic health conditions. Below are five notable advancements that highlight the progress in this dynamic field.

• Development of 3D-Printed Organs: Researchers are making strides in 3D bioprinting technologies, creating scaffold structures that mimic human organs, potentially reducing transplant waiting lists.
• Next-Generation Artificial Hearts: New designs of artificial hearts featuring biomaterials and improved energy efficiency are being tested, offering greater longevity and better integration with the human body.
• Smart Bionic Limbs: Recent advancements in bionic prosthetics include AI-driven models that adapt to the user's movements, providing real-time adjustments for enhanced mobility and functionality.
• Improved Dialysis Machines: Innovations in dialysis technology focus on more portable and efficient machines that provide better filtration and reduced recovery time for patients with kidney failure.
• Wearable Organ Support Devices: The introduction of portable organ support systems, such as wearable artificial lungs, allows patients with respiratory issues to maintain a higher quality of life while awaiting transplants.

These recent developments demonstrate ongoing innovation in vital organ support and bionic technologies, paving the way for improved patient outcomes and more effective treatments.

Strategic Growth Opportunities for Vital Organ Support Systems and Medical Bionic Market

The vital organ support systems and the medical bionic market are ripe with strategic growth opportunities driven by technological advancements and changing patient needs. Companies and stakeholders can capitalize on these opportunities to enhance their offerings and expand their market presence. Here are five key areas for growth within this dynamic industry.

• Investment in Research and Development: Increased funding for R&D can lead to breakthroughs in organ regeneration and bionic technology, creating innovative products that meet evolving healthcare demands.
• Expansion into Emerging Markets: Targeting emerging economies offers a chance to provide affordable bionic solutions and organ support systems, addressing healthcare gaps and increasing access to essential technologies.
• Collaborations with Tech Companies: Partnering with technology firms can enhance product capabilities, integrating AI, IoT, and data analytics to improve the performance and usability of medical devices.
• Personalized Medicine Approaches: Developing customized organ support systems based on individual patient profiles can significantly improve treatment efficacy, catering to specific needs and enhancing outcomes.
• Focus on Rehabilitation Technologies: Investing in advanced rehabilitation solutions for bionic limb users can create new markets, ensuring patients regain full functionality and improve their quality of life.

By leveraging these strategic growth opportunities, stakeholders in the vital organ support and medical bionic sectors can drive innovation and improve patient care while expanding their market reach.

Vital Organ Support Systems and Medical Bionic Market Driver and Challenges

The vital organ support systems and medical bionic market are influenced by various drivers and challenges that shape its growth trajectory. Understanding these factors is essential for stakeholders aiming to navigate this evolving landscape effectively. Here are five key drivers fueling growth and three challenges that may hinder progress in this sector.

The factors responsible for driving the vital organ support systems and medical bionic market include:

• Increasing Incidence of Chronic Diseases: The rising prevalence of chronic conditions such as diabetes, heart disease, and kidney failure drives demand for organ support systems and bionic solutions to improve patient outcomes.
• Technological Advancements: Continuous innovations in materials, AI, and robotics enhance the functionality and efficiency of medical bionic devices, making them more appealing to both healthcare providers and patients.
• Aging Population: The growing elderly demographic contributes to increased healthcare needs, including organ support and prosthetics, thereby expanding the market for these essential technologies.
• Favorable Regulatory Environment: Supportive regulations and incentives from governments worldwide foster research and development, accelerating the approval processes for innovative medical devices.
• Rising Healthcare Expenditure: Increased spending on healthcare services and technology allows for greater investment in advanced organ support and bionic systems, driving market growth.

Challenges in the vital organ support systems and medical bionic market include:

• High Development Costs: The significant financial investment required for R&D and regulatory compliance can be a barrier for new entrants and smaller companies looking to innovate in this space.
• Regulatory Hurdles: Complex regulatory pathways and stringent approval processes can delay the introduction of new technologies, hindering timely access to life-saving devices for patients.
• Limited Awareness and Accessibility: A lack of awareness about available solutions, coupled with socioeconomic factors, can restrict access to vital organ support and bionic technologies, especially in underserved communities.

While the vital organ support and medical bionic market is propelled by strong drivers, it also faces challenges that must be addressed to ensure sustainable growth and improved patient care.

List of Vital Organ Support Systems and Medical Bionic Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, vital organ support systems and medical bionic companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the vital organ support systems and medical bionic companies profiled in this report include-

• Abbott Laboratories
• Abiomed
• Baxter International
• Asahi Kasei
• Cochlear
• Boston Scientific
• Jarvik Heart
• Edwards Lifesciences
• Ossur Americas
• Medtronic

Vital Organ Support Systems and Medical Bionic by Segment

The study includes a forecast for the global vital organ support systems and medical bionic market by product type, end use, and region.

Vital Organ Support Systems and Medical Bionic Market by Product Type [Analysis by Value from 2019 to 2031]:

• Vital organs support system
• Medical Bionics
• Orthopedic Bionics
• Cardiac Bionics
• Neural Bionics

Vital Organ Support Systems and Medical Bionic Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospital
• Ambulatory Surgical Center
• Others

Vital Organ Support Systems and Medical Bionic Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Vital Organ Support Systems and Medical Bionic Market

The field of vital organ support systems and medical bionics has seen significant advancements across the globe. Innovations are emerging from the US, Indian, German, and Japanese markets, reflecting a growing emphasis on improving patient care through technology. Here are the latest updates from each country.

• United States: The US has seen breakthroughs in artificial organs, including the development of advanced bioprosthetic hearts that enhance the quality of life for patients awaiting transplants.
• China: The Chinese focus on regenerative medicine is driving progress in bioengineered organs, with universities collaborating on innovative 3D-printed organ prototypes for transplant applications.
• Germany: Germany is leading in robotic bionic limbs, with new models featuring enhanced sensory feedback that allows for more natural movement and improved integration with the human body.
• India: India is expanding its market for affordable bionic devices and has recently launched initiatives to develop low-cost prosthetics that improve accessibility for underserved populations.
• Japan: Japan is pioneering smart wearable devices that support organ function by integrating AI to monitor vital signs and provide real-time health data to caregivers and patients alike.

Features of the Global Vital Organ Support Systems and Medical Bionic Market

Market Size Estimates: Vital organ support systems and medical bionic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Vital organ support systems and medical bionic market size by product type, end use, and region in terms of value ($B).

Regional Analysis: Vital organ support systems and medical bionic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, end uses, and regions for the vital organ support systems and medical bionic market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the vital organ support systems and medical bionic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the vital organ support systems and medical bionic market by product type (vital organs support system, medical bionics, orthopedic bionics, cardiac bionics, and neural bionics), end use (hospital, ambulatory surgical center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Vital Organ Support Systems and Medical Bionic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Vital Organ Support Systems and Medical Bionic Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Vital Organ Support Systems and Medical Bionic Market by Product Type
  • 3.3.1: Vital organs support system
  • 3.3.2: Medical Bionics
  • 3.3.3: Orthopedic Bionics
  • 3.3.4: Cardiac Bionics
  • 3.3.5: Neural Bionics
• 3.4: Global Vital Organ Support Systems and Medical Bionic Market by End Use
  • 3.4.1: Hospital
  • 3.4.2: Ambulatory Surgical Center
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Vital Organ Support Systems and Medical Bionic Market by Region
• 4.2: North American Vital Organ Support Systems and Medical Bionic Market
  • 4.2.1: North American Market by Product Type: Vital organs support system, Medical Bionics, Orthopedic Bionics, Cardiac Bionics, and Neural Bionics
  • 4.2.2: North American Market by End Use: Hospital, Ambulatory Surgical Center, and Others
• 4.3: European Vital Organ Support Systems and Medical Bionic Market
  • 4.3.1: European Market by Product Type: Vital organs support system, Medical Bionics, Orthopedic Bionics, Cardiac Bionics, and Neural Bionics
  • 4.3.2: European Market by End Use: Hospital, Ambulatory Surgical Center, and Others
• 4.4: APAC Vital Organ Support Systems and Medical Bionic Market
  • 4.4.1: APAC Market by Product Type: Vital organs support system, Medical Bionics, Orthopedic Bionics, Cardiac Bionics, and Neural Bionics
  • 4.4.2: APAC Market by End Use: Hospital, Ambulatory Surgical Center, and Others
• 4.5: ROW Vital Organ Support Systems and Medical Bionic Market
  • 4.5.1: ROW Market by Product Type: Vital organs support system, Medical Bionics, Orthopedic Bionics, Cardiac Bionics, and Neural Bionics
  • 4.5.2: ROW Market by End Use: Hospital, Ambulatory Surgical Center, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Vital Organ Support Systems and Medical Bionic Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Vital Organ Support Systems and Medical Bionic Market by End Use
  • 6.1.3: Growth Opportunities for the Global Vital Organ Support Systems and Medical Bionic Market by Region
• 6.2: Emerging Trends in the Global Vital Organ Support Systems and Medical Bionic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Vital Organ Support Systems and Medical Bionic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Vital Organ Support Systems and Medical Bionic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: Abiomed
• 7.3: Baxter International
• 7.4: Asahi Kasei
• 7.5: Cochlear
• 7.6: Boston Scientific
• 7.7: Jarvik Heart
• 7.8: Edwards Lifesciences
• 7.9: Ossur Americas
• 7.10: Medtronic